On August 31, 2026, China Universal Asset Management Co., Ltd. bought 30,800 shares of SKB BIO (06990) at an average of HKD 492.9088 per share, involving about HKD 15.18 million.
Prior to the acquisition, China Universal Asset Management Co., Ltd.'s long position in SKB BIO was 8.84 million shares, representing 4.99%; following the acquisition, the holding changed to 8.87 million shares, with the long position ratio rising to 5.01%.